Roswitha Verwer and Dr. Muskaan Bhan share their journey from preclinical validation through regulatory approval, currently at TRL4, pursuing CE Mark and FDA De Novo. The conversation offers insights into how real-time biomarker data can transform women’s reproductive health while overcoming investor skepticism, taboo, and market barriers when solving decades-old clinical blind spots in women’s health.

Roswitha Verwer en YON E Health bouwen aan een nieuwe generatie FemTech-innovatie door real-time data over vaginale gezondheid toegankelijk te maken voor vrouwen.

Peter Kovacs features Roswitha Verwer and Muskaan Bhan on Clinical Capital Conversations, exploring how she scales FemTech with precision, purpose, and science-driven innovation in women’s health.

YON E Health raises €250k pre-Seed to advance a first-of-its-kind smart vaginal health device measuring pH and temperature for fertility, infection risk, and reproductive wellbeing, strengthening Europe’s growing FemTech market with science-backed, women-centered innovation.

YON E Health was highlighted by Founders Amplified for its medical device innovation advancing vaginal health data, FemTech research, and stigma-free women’s healthcare.

Founder Roswitha Verwer shares insights on FemTech, vaginal health innovation, fertility awareness, resilience, and values-driven leadership on the Productive Passions Podcast.

Interview with Roswitha Verwer, founder of YON E Global, on building a patent-pending femtech device, launching a European femcare webshop, and navigating funding challenges in women’s health. Covers mission, milestones, and global growth in digital health.